Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s Trulicity can cause cancer of the thyroid. Six months ago, the Pharmacovigilance Risk ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

“Thyroid cancer continues to be overdiagnosed at peak levels without any significant improvement.” The researchers of the JAMA study initially set out to revisit the question of whether GLP-1 ...

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

A recent study suggests that GLP-1 receptor agonists (GLP-1RAs) may lower the risk of hematologic cancers, including leukemia ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...